000 | 02965nam a22003377a 4500 | ||
---|---|---|---|
008 | 240723s20242024 xxu||||| |||| 00| 0 eng d | ||
022 | _a2701-0198 | ||
040 | _aOvid MEDLINE(R) | ||
099 | _a38419396 | ||
245 | _aExploring the Impact of TLR-2 Signaling on miRNA Dysregulation in Intervertebral Disc Degeneration. | ||
251 | _aAdvances in Biology Online. :e2300581, 2024 Feb 28 | ||
252 | _aadv. biol. :e2300581, 2024 Feb 28 | ||
253 | _aAdvanced biology | ||
260 | _c2024 | ||
260 | _p2024 Feb 28 | ||
265 | _saheadofprint | ||
265 | _tPublisher | ||
266 | _d2024-07-23 | ||
520 | _aToll-like receptors (TLRs) are key mediators of inflammation in intervertebral disc (IVD) degeneration. TLR-2 activation contributes to the degenerative process by increasing the expression of extracellular matrix-degrading enzymes, pro-inflammatory cytokines, and neurotrophins. As potent post-transcriptional regulators, microRNAs can modulate intracellular mechanisms, and their dysregulation is known to contribute to numerous pathologies. This study aims to investigate the impact of TLR-2 signaling on miRNA dysregulation in the context of IVD degeneration. Small-RNA sequencing of degenerated IVD cells shows the dysregulation of ten miRNAs following TLR-2 activation by PAM2CSK4. The miR-155-5p is most significantly upregulated in degenerated and non-degenerated annulus fibrosus and nucleus pulposus cells. Sequence-based target and pathway prediction shows the involvement of miR-155-5p in inflammation- and cell fate-related pathways and TLR-2-induced miR-155-5p expression leads to the downregulation of its target c-FOS. Furthermore, changes specific to the activation of TLR-2 through fragmented fibronectin are seen in miR-484 and miR-487. Lastly, miR-100-3p, miR-320b, and miR-181a-3p expression exhibit degeneration-dependent changes. These results show that TLR-2 signaling leads to the dysregulation of miRNAs in IVD cells as well as their possible downstream effects on inflammation and degeneration. The identified miRNAs provide important opportunities as potential therapeutic targets for IVD degeneration and low back pain. Copyright © 2024 The Authors. Advanced Biology published by Wiley-VCH GmbH. | ||
546 | _aEnglish | ||
650 | _zAutomated | ||
650 | _aIN PROCESS -- NOT YET INDEXED | ||
651 | _aMedStar Washington Hospital Center | ||
656 | _aOrthopedic Surgery | ||
657 | _aJournal Article | ||
700 |
_aMesfin, Addisu _bMWHC |
||
790 | _aCazzanelli P, Lamoca M, Hausmann ON, Mesfin A, Puvanesarajah V, Hitzl W, Haglund L, Wuertz-Kozak K | ||
856 |
_uhttps://dx.doi.org/10.1002/adbi.202300581 _zhttps://dx.doi.org/10.1002/adbi.202300581 |
||
858 |
_yCazzanelli, Petra _uhttps://orcid.org/0009-0007-3114-951XI - Wuertz-Kozak, Karin _uhttps://orcid.org/0000-0002-3281-4629 _zhttps://orcid.org/0009-0007-3114-951XI - Wuertz-Kozak, Karin _zhttps://orcid.org/0000-0002-3281-4629 |
||
942 |
_cART _dArticle |
||
999 |
_c14223 _d14223 |